Common Stock Dark or Defunct
Pink No Information

OTC Disclosure & News Service


Polaris International Holdings, Inc., to Release Brain Health Supplement

May 21, 2014

OTC Disclosure & News Service

- Polaris International Holdings, Inc., to Release Brain Health Supplement

Polaris International Holdings, Inc., to Release Brain Health Supplement

PLANO, TX--(Marketwired - May 21, 2014) - Polaris International Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is pleased to announce that it is releasing a brain health supplement as part of its hemp based nutraceutical supplement line. The Company is set to launch this product in the 4th quarter of 2014 to go along with its hemp protein powder supplements. 

Essential Fatty Acids make up a large portion of the brain, hemp is especially beneficial for brain health, particularly memory function. The membrane loss of Essential Fatty Acids has been found in such brain disorders as Alzheimer's and Parkinson's diseases. A proper balance of omega-6 to omega-3 fatty acids -- such as in hemp may help reduce the neurological effects of these diseases and improve quality of life. 

Medical Director, Dr. Avila states, "We are really looking forward to releasing our nutraceutical line of products. We feel that our nutraceutical products will improve our customers' health and quality of life. We will continue to update our investors with more product news in the coming days."

Polaris International Holdings, Inc.'s line ProCannas, focuses on the manufacture and distribution of new, pharmaceutical grade cannabinoid based products for medicinal use. With the Joint Venture 70 acre hemp farm in Kentucky, the Company will grow and develop a large portion of its own hemp products. The Company is also launching a nutraceutical line of products in the Fall of 2014. Laws are expected to become even more favorable for companies like ProCannas. The Company intends to target a broad range of specialties with this novel product, including but not limited to sports medicine, pain management, neurology, and osteopathic medicine.

Safe Harbor Statement:
This news release includes forward-looking statements pertaining to future anticipated projected plans, performance and developments, intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Any statements on this news release that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates," "intends," or other words or phrases of similar import. Similarly, statements in this news release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Investor Inquiries:
Polaris International Holdings, Inc.

Copyright © 2014 Marketwired. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.